Improving Diagnosis and Clinical Monitoring of Acid Sphingomyelinase Deficiency
* Overview of olipudase alfa * Efficacy and safety of olipudase alfa from phase 2 and 3 trials
Be the first to comment
Sign up now and become a member of the Improving Diagnosis and Clinical Monitoring of Acid Sphingomyelinase Deficiency community!
Then 99 kr. / month · Cancel anytime
5 episodes
Emerging Therapies: Efficacy and Safety Data from Phase 3 Trials
Clinical Management and Treatment Monitoring Part 2
* Surveillance recommendations for patients with ASMD * Ongoing symptomatic management and support * Role of liver transplantation
Clinical Management and Treatment Monitoring Part 1
* Initial evaluation and management of ASMD * Clinical trial enrollment
Guidelines for the Diagnosis of ASMD
* Clinical presentations of ASMD * Diagnostic algorithms * Enzymatic testing
Defining ASMD
* Pathophysiology of ASMD * ASMD phenotypes
Comments
0Be the first to comment
Sign up now and become a member of the Improving Diagnosis and Clinical Monitoring of Acid Sphingomyelinase Deficiency community!